1.Protective effects of bismuth nitrate against the nephrotoxicity of mercuric chloride and gentamicin.
Hae Young CHUNG ; Jong Deog KIM ; Jeong Sun KIM ; Pil Sun KIM ; Han Suk YOUNG ; Yung Jae RHO ; Suk Soo SUH
Korean Journal of Nephrology 1991;10(1):49-53
No abstract available.
Bismuth*
;
Gentamicins*
;
Mercuric Chloride*
2.Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection.
In Woong HAN ; Jin Young JANG ; Mee Joo KANG ; Wooil KWON ; Jae Woo PARK ; Ye Rim CHANG ; Sun Whe KIM
Annals of Surgical Treatment and Research 2014;87(2):87-93
PURPOSE: Extended liver resection may provide long-term survival in selected patients with Bismuth type IV hilar cholangiocarcinoma (HCCA). The purpose of this study was to identify anatomical factors that predict curative-intended resection. METHODS: Thirty-three of 159 patients with Bismuth type IV HCCA underwent major hepato-biliary resection with curative intent (CIR) between 2000 and 2010. Disease extent and anatomical variations were analyzed as factors enabling CIR. RESULTS: CIR ratio with hilar trifurcation bile duct variation (13/16) was significantly higher than that with other bile duct variation types (18/25). Hilum to left second bile duct confluence and tumor infiltration over left second bile duct confluence lengths in right-sided CIR were significantly shorter than those lengths in left-sided CIR (10.8 +/- 4.9 and 2.7 +/- 0.8 mm vs. 16.5 +/- 8.4 and 7.0 +/- 5.3 mm, respectively). Left-sided CIR patients had a marginally higher proportion of tumors invading < or =5 mm over the right second confluence than that in right-sided CIR patients (13/17 vs. 6/16; P = 0.061). The 3-year survival rate after CIR (28%) was significantly higher than after non-CIR (6.1%). CONCLUSION: We recommend the criteria of CIR as bile duct variation type, length of hilum to contralateral second bile duct confluence, and extent of tumor infiltration over the second confluence for Bismuth type IV HCCA.
Bile Ducts
;
Bismuth*
;
Cholangiocarcinoma*
;
Humans
;
Klatskin's Tumor
;
Liver
;
Survival Rate
3.Efficacy and Safety of Albis(R) in Acute and Chronic Patients with Gastritis: A Double-blind, Placebo-controlled, Randomized Multi-center Study.
Hae Won HAN ; Myung Gyu CHOI ; Sang Young SEOL ; Dong Ho LEE ; Hwoon Yong JUNG ; Tae Nyeun KIM ; Suck Chei CHOI ; Hyen Soo KIM
Korean Journal of Gastrointestinal Endoscopy 2011;42(4):215-221
BACKGROUND/AIMS: Albis(R) is a newly developed drug comprised of ranitidine, bismuth and sucralfate. The aim of the study was to demonstrate the efficacy and safety superiority of Albis(R) compared to Stillen(R) for treating erosive gastritis. METHODS: This study was a randomized, double-blind, multi-center trial. The primary endpoint was 2 weeks of treatment. RESULTS: Of the 229 patients in the intention-to-treat (ITT) population, 87 from the Albis(R), and 96 from the Stillen(R) group were included in the per protocol (PP) analysis. The endoscopic improvement rate was not different between the Albis(R)(R) group and the control in both the PP (42.5%, 39.6%) and ITT (35.3%, 34.5%) populations. The endoscopic cure of erosion was also not different in the Albis(R) group than that in the control group in both the PP (32.3%, 31.3%) and ITT (27.6%, 27.4%) populations. The endoscopic improvement rate for hemorrhage, edema, and erythema were also not different between the two groups in both the PP and ITT populations. No statistically significant differences were observed for adverse events between the two groups. CONCLUSIONS: Half of the approved dose of Albis(R) for peptic ulcers was superior to Stillen(R). A low dosage of Albis(R) is more cost efficient and safe than that of Stillen(R).
Bismuth
;
Edema
;
Erythema
;
Hemorrhage
;
Humans
;
Peptic Ulcer
;
Ranitidine
;
Sucralfate
4.Functional Significance of Stress-relieving Act of Chewing and it Effect on Brain Activation by Strees
Masami NIWA ; Itaru HIRAMATSU ; Fumiaki NAKATA ; Chika HAMAYA ; Nobuhito ONOGI ; Koshiro SAITO
Journal of the Japanese Association of Rural Medicine 2005;54(4):661-666
The chewing-related neuronal mechanism underlying stress relief, was evaluated by use of fMRI. For this purpose we examined the effect of chewing a moderately hard gum without any taste (X type, Lotte Co. LTd., Tokyo) on brain activation caused by a noisy sound stress, on plasma levels of catecholamines and ACTH. The stress significantly increased the blood oxygenation level-dependent (BOLD) signals in the amygdala and the medial prefrontal cortex, and elevated plasma levels of noradrenaline, dopamine and ACTH. However, this chewing suppressed not only the stress-induced increase in BOLD signals in these two regions, but also the stress-induced elevation in plasma levels of these catecholamines and ACTH. The results suggested that chewing might be a useful therapy for reducing stress.
Stress
;
Mastication
;
Adrenocorticotropic hormone measurement
;
Plasma
;
Stress bismuth subsalicylate
5.Life Events and Posttraumatic Stress in Hanshin-Awaji Earthquake Victims
Young-Sook KWON ; Soichiro MARUYAMA ; Kanehisa MORIMOTO
Environmental Health and Preventive Medicine 2001;6(2):97-103
Stress induced by disaster is experienced to varying degrees by all respondents, and is known to evoke psychophysiological reactions. In this study, we investigated the relationships between earthquake-related life events and posttraumatic stress symptoms. A total of 380 adults were surveyed one year after the 1995 Hanshin-Awaji earthquake in Japan. The questionnaire included items concerning earthquake-related life events, emotional support and posttraumatic stress disorder (PTSD) symptoms. As a result, after controlling for demographic variables, earthquake-related life events were significantly related to the grade of posttraumatic stress and its three components: re-experience, avoidance and arousal, in both male and female subjects. Male subjects who currently had lower emotional support showed higher scores of posttraumatic stress and arousal. In conclusion, a higher experience of earthquake-related life events appears to be an important risk factor for development of poor mental health status following an earthquake disaster.
Earthquakes
;
Life events
;
seconds
;
Stress bismuth subsalicylate
;
Stress
6.Perturbation of Secretory Ig A in Saliva and Its Daily Variation by Academic Stress
Zhong-Qiu GUO ; Takemi OTSUKI ; Yasuhisa ISHII ; Aya INAGAKI ; Youichiro KAWAKAMI ; Yuki HISANO ; Riichiro YAMASHITA ; Kenta WANI ; Haruko SAKAGUCHI ; Satoshi TSUJITA ; Kanehisa MORIMOTO ; Ayako UEKI
Environmental Health and Preventive Medicine 2001;6(4):268-272
Objectives: Several studies have reported that the secretory immunoglobulin A (S-IgA) concentration in saliva is an indicator of psychological stress. The aim of this study was to clarify the relationship between S-IgA and the stress from academic examinations. Methods: S-IgA levels in 10 medical student volunteers from the second year course between May 4 and July 13, 2000 were examined using the ELISA method. Results: There was a tendency for S-IgA in saliva to be higher on the day before academic examinations and during them, and lower on the days between these examinations. Conclusions: It may be possible to use this measurement to monitor psychological stress in students and workers.
Upper case ess
;
Immunoglobulin A measurement
;
Saliva
;
Stress bismuth subsalicylate
;
Daily
7.Management of Helicobacter pylori Infection in Europe: Focusing on the Maastricht V/Florence Consensus.
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2017;17(1):11-15
In the fifth edition of the Maastricht Consensus Conference, quadruple regimens for primary treatment of Helicobacter pylori infection such as concomitant or bismuth quadruple therapy have been recommended in areas of high clarithromycin resistance. In addition, the Maastricht Consensus V highlighted the importance of population- and individual-based susceptibility tests to detect possible antibiotic resistance in patients with a history of intake of any of the key antibiotics, even if the population has a low resistance rate.
Anti-Bacterial Agents
;
Bismuth
;
Clarithromycin
;
Consensus*
;
Drug Resistance, Microbial
;
Europe*
;
Helicobacter pylori*
;
Helicobacter*
;
Humans
8.Therapeutic Efficacy of Dual Therapy and Triple Therapy for Helicobacter pylori Infection in Children.
Sun Hwan BAE ; Jae Sung KOH ; Jeong Kee SEO
Journal of the Korean Pediatric Society 1998;41(3):323-330
PURPOSE: An optimal treatment for Helicobacter pylori (H. pylori) infection in children has not yet been established. In this study, the efficacy and the tolerability of triple therapy with colloidal bismuth subcitrate (CBS), amoxicillin and metronidazole, were evaluated in comparison with dual therapy with CBS and amoxicllin. METHODS: Eighty-six children with H. pylori infection, aged 6 years to 14 years, were enrolled in this study. H. pylori infection was confirmed by endoscopic antral biopsy with an rapid urease test, culture and a modified Giemsa stain. The children were considered positive for H. pylori infection if culture was positive or if both modified Giemsa staining and CLO test were positive. The children were treated with one of the following three regimens. Dual therapy with CBS for 4 weeks and amoxicillin for 2 weeks (Group I. n=57: 1993.8-1995.1), Triple therapy with CBS for 4 weeks, amoxcillin for 2 weeks and metronidazole for 2 weeks (Group IIa. n=11: 1995.2-1995.7), and Triple therapy with CBS for 2 weeks, amoxicillin for 2 weeks and metronidazole for 2 weeks (Group IIb. n=18 : 1995. 8-1996. 6). A 50mg/kg/d dose of amoxcillin was aclministered, and that of CBS was 7-8mg/kg/d, and that of metronidazole was 20mg/kg/d. About one month after the cessation of treatment, eradication of H. pylori was evaluated with repeated endoscopic biopsy. RESULTS: H. pylori eradication rate was 61.4% (35/57) in Group I, 90.9% (10/11) in Group IIa, and in the absence of H. pylori 88.9% (16/18) of Group IIb was done by means of an urease test, culture and a modified Giemsa stain (P=0.012). The overall proportion of eradication of H. pylori infection was 89.7% (26/29) by triple therapy and 61.4% (35/57) by dual therapy (P=0.007). However, there was no statistically significant difference in eradication rate between the 2-week triple therapy (IIb) and the Denol 4-week triple therapy (IIa)(P=0.86). Side effects : All patients in three treatment groups were tolerated well with little and mild side effects (P=0.258). CONCLUSION: The 2-week triple therapy with CBS, amoxcillin, and metronidazole would be a highly effective and safe treatment regimen for H. pylori infection in children.
Amoxicillin
;
Azure Stains
;
Biopsy
;
Bismuth
;
Child*
;
Colloids
;
Helicobacter pylori*
;
Helicobacter*
;
Humans
;
Metronidazole
;
Urease
;
Withholding Treatment
9.Metronidazole Resistance and the Eradication of Helicobacter pylori.
Gwang Ho MUN ; Joon Soo HAHM ; Kwang Hyun RYU ; Oh Young LEE ; Dong Soo HAN ; Byung Chul YOON ; Ho Soon CHOI ; Min Ho LEE ; Choon Suhk LEE ; Kyung Nam PARK ; Jung Ok KANG
Korean Journal of Gastrointestinal Endoscopy 1998;18(6):847-852
BACKGROUND/AIMS: The success of Helicobacter pylori eradication is limited by antibiotic resistances, and the primary resistance to metranidazole seems to be high. In this study, the frequency af metronidazole resistance and the eradication rate in metronidazole-resistant H. pylori strain was evaluated. METHODS: Sixty-eight patients were tested for metronidazole resistance using microdilution broth, the E test and disk diffusion method. Twenty-two patients were treated for 14 days with amoxicilline 2000 mg, metronidazole 750 mg, and tripotassium dicitrate bismuth 1200 mg. RESULTS: Metronida-zole resistance was 46% (31/68). The eradication rates for H. pylori was 91.7% in patients with metronidazole-sensistive strains and 70% in patients with metronidazole-resistant strains. CONCLUSIONS: Metronidazole resistance was high (46%) in Korea, however, triple therapy was an efficient method of eradicating H. pylori in both metronidazole sensitive and resistant strains.
Amoxicillin
;
Bismuth
;
Diffusion
;
Helicobacter pylori*
;
Helicobacter*
;
Humans
;
Korea
;
Metronidazole*
;
Peptic Ulcer
10.Photodynamic Therapy in Unresectable Cholangiocarcinoma: Not for the Uncommitted.
Jayant P TALREJA ; Marisa DEGAETANI ; Kristi ELLEN ; Timothy SCHMITT ; Monica GAIDHANE ; Michel KAHALEH
Clinical Endoscopy 2013;46(4):390-394
BACKGROUND/AIMS: Photodynamic therapy (PDT) in unresectable cholangiocarcinoma has been associated with improved survival. We report a single tertiary care center experience over the past 6 years. METHODS: Fifty-five patients with unresectable cholangiocarcinoma received PDT between 2004 and 2010. Plastic stents were placed after PDT to prevent cholangitis. RESULTS: Twenty-seven patients (49%) showed Bismuth type IV, 22 (41%) showed Bismuth type III, and six (10%) showed Bismuth type I and II. Twenty patients (37%) received chemotherapy and radiation therapy, five (9%) received chemotherapy only; and one (2%) received radiation therapy only. Mean number of PDT sessions was 1.9+/-1.5 sessions (range, 1 to 9). Mean survival duration was 293+/-266 days (median, 190; range, 25 to 1,332). PDT related complications included three (5%) facial burn, three (5%) photosensitivity, and two (3%) rash. Kaplan-Meier analysis comparing the survival means of patients who received PDT and chemotherapy/radiation therapy (median survival 257 days; 95% confidence interval [CI], 166 to 528) versus who received PDT only (median survival 183 days; 95% CI, 129 to 224) showed no significant difference (log-rank p=0.20). CONCLUSIONS: PDT has a measurable impact on survival in unresectable cholangiocarcinoma but requires aggressive stenting posttherapy.
Bismuth
;
Burns
;
Cholangiocarcinoma
;
Exanthema
;
Humans
;
Kaplan-Meier Estimate
;
Photochemotherapy
;
Plastics
;
Stents
;
Tertiary Care Centers
;
Triazenes